NEW BRUNSWICK, N.J., Feb. 17 - Johnson & Johnson (NYSE: JNJ) today announced the completion of its previously announced acquisition of Animas Corporation, an insulin delivery company.
Johnson & Johnson is the world's most comprehensive and broadly based manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical, and medical devices and diagnostics markets. The more than 200 Johnson & Johnson operating companies employ approximately 115,600 men and women in 57 countries and sell products throughout the world.
